Clinical and Radiographic Evaluation of Potassium Nitrate in Polycarboxylate Versus Mineral Trioxide Aggregate in Vital Pulpotomy in Primary Molars
Launched by CAIRO UNIVERSITY · Mar 6, 2025
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different materials used in a dental procedure called pulpotomy, which helps save children's teeth that have deep cavities but are still healthy. The researchers want to compare potassium nitrate mixed with a type of dental cement (polycarboxylate) and mineral trioxide aggregate (MTA) to see which one works better in keeping the tooth healthy until it naturally falls out to make way for permanent teeth. This study is important because it aims to avoid removing the entire pulp (the soft tissue inside the tooth) while still treating the tooth effectively.
To participate in this trial, children aged 4 to 7 years who are in good health and have certain types of cavity issues in their primary molars may be eligible. They should not have any signs of pain, swelling, or other serious dental conditions. If enrolled, children will receive one of the two treatments and will need to come back for follow-up visits to monitor how well their tooth is healing. This study is not yet recruiting participants, but it aims to help improve dental care for young children with similar dental issues in the future.
Gender
ALL
Eligibility criteria
- ❖ Inclusion Criteria:
- • 1. Children aged 4 to 7 years, in good general health.
- • 2. Children with vital, deeply carious primary molars.
- • 3. No history of spontaneous pain, pathological mobility, draining sinus tract, redness or swelling of the vestibule.
- • 4. Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.
- • 5. No sign of radiolucency in periapical or furcation area.
- • 6. No widening of PDL space or loss of lamina dura continuity.
- • 7. No evidence of internal/external pathological root resorption.
- Exclusion Criteria:
- • 1. Children with a physical disability or medical disability.
- • 2. Unrestorable molars.
- • 3. Uncooperative patient.
- • 4. Parent unable to attend Follow- up visits.
- • 5. Parents refuse to give written informed consent.
- • 6. If the access was opened and irreversible pulpitis was evident.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported